For the HCC samples (n = 115), the proportions were as follows: CP2c low/nuclear YY1 low (24.3%), CP2c low/nuclear YY1 high (2.6%), CP2c high/nuclear YY1 low (18.3%), and CP2c high/nuclear YY1 high (54.8%) expression. The gene discussed is YY1; the disease is hepatocellular carcinoma.